1. Letter: Safety and Efficacy of the Off-Label Use of Pipeline Embolization Device Based on the 2018 Food and Drug Administration-Approved Indications for Intracranial Aneurysms: A Single-Center Retrospective Cohort Study. Issue 5 (24th November 2022) Authors: Cler, Samuel J.; Lauzier, David C.; Kansagra, Akash P. Journal: Neurosurgery Issue: Volume 91:Issue 5(2022) Page Start: e135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗